Literature DB >> 22711316

HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature.

Guler Yavas1, Pinar Karabagli, Murat Araz, Cagdas Yavas, Ozlem Ata.   

Abstract

Primary pure neuroendocrine carcinoma of the breast is an extremely rare tumor. We report a case of primary solid neuroendocrine carcinoma in a 77-year-old postmenopausal woman who was admitted to the hospital with masses on her right breast and axillary region. Radical mastectomy with axillary lymph node resection was performed. Immunohistochemical stainings of the tumor cells with synaptophysin, GCDFP-15, estrogen, progesterone, and c-erbB-2 were positive. Five of 16 lymph nodes were metastatic. She did not receive adjuvant chemotherapy. After 15 months of follow-up she is free of the disease. Literature review revealed that this is the second case of HER-2 positive primary neuroendocrine tumor of the breast.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711316     DOI: 10.1007/s12282-012-0382-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  4 in total

1.  Dramatic response to cyclin D-dependent kinase 4/6 inhibitor in refractory poorly differentiated neuroendocrine carcinoma of the breast.

Authors:  Allison Shanks; Julia Choi; Vinit Karur
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-09

Review 2.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

3.  Rare Human Epidermal Growth Factor Receptor 2 (HER-2)-Positive Neuroendocrine Carcinoma of the Breast: A Case Report with 9-Year Follow-up.

Authors:  Inga Marijanović; Marija Kraljević; Teo Buhovac; Dragana Karan Križanac
Journal:  Am J Case Rep       Date:  2020-10-17

4.  Primary neuroendocrine tumour of the breast: a case report and review of the literature.

Authors:  Sara Tato-Varela; Rosa Albalat-Fernández; Sara Pabón-Fernández; Enrique Rodríguez Zarco; Manolo La Calle-Marcos
Journal:  Ecancermedicalscience       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.